Development and validation of a liquid chromatography-mass spectrometry (LC-MS) assay for the determination of the anti-cancer agent N-[2-(dimethylamino)ethyl]-2,6-dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide (SN 28049)
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-11-15
著者
-
Kestell P
Auckland Cancer Society Research Centre The University Of Auckland
-
Paxton J
Division Of Pharmacology And Clinical Pharmacology Faculty Of Medical And Health Sciences The Univer
-
Paxton James
Department Of Pharmacology And Clinical Pharmacology Faculty Of Medical And Health Sciences The Univ
-
KESTELL Philip
Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of A
-
BAGULEY Bruce
Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of A
-
Paxton James
Department Of Pharmacology & Clinical Pharmacology The University Of Auckland
-
LUKKA Pradeep
Auckland Cancer Society Research Centre, The University of Auckland
-
Lukka Pradeep
Auckland Cancer Society Research Centre The University Of Auckland
-
Baguley Bruce
Auckland Cancer Society Research Centre The University Of Auckland
関連論文
- Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detection
- Interposition of a Jejunal Segment as an Alternative One-Stage Operation for Acute Left Colon Obstruction
- Determination of unbound concentration of the novel anti-tumour agent 5, 6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detection
- Determination of the covalent adducts of the novel anti-cancer agent 5, 6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography
- Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection : application to transport studies
- Development and validation of a liquid chromatography-mass spectrometry (LC-MS) assay for the determination of the anti-cancer agent N-[2-(dimethylamino)ethyl]-2,6-dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide (SN 28049)